Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The GUMMMy Bear Squad touting Gum Tech (NASDAQ: GUMM) -- Ignore unavailable to you. Want to Upgrade?

To: StockMiser who wrote (140)	2/6/2000 9:12:00 PM
From: Mad2	Respond to of 207

Interesting. So much for science. This issue appears more and more like experts at a trial. One side says one thing, the other the opposite and they are both experts......differentiating feature is usually who picks up the tab. Well.....in the case of GUMM, its revenue and profit thats important. It will be interesting to follow. I'll guess that Zicam behaves a bit like any other consumer product....with sales being dependant upon advertizing and creating demand amongst consumers. It will be interesting to see if Zicam sticks or fades. What I mean is that other materials (antihistamines) provide a immediate form of relief, Zicam if not percived (perhaps due to methode of use) to work won't be tried again.